Chartwell Investment Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,013
| Closed | -$281K | – | 417 |
|
|
2024
Q1 | $281K | Sell |
4,013
-22,440
| -85% | -$1.57M | 0.01% | 405 |
|
|
2023
Q4 | $2.21M | Buy |
26,453
+2,950
| +13% | +$246K | 0.08% | 274 |
|
|
2023
Q3 | $692K | Hold |
23,503
| – | – | 0.03% | 374 |
|
|
2023
Q2 | $767K | Buy |
23,503
+1,142
| +5% | +$37.3K | 0.03% | 370 |
|
|
2023
Q1 | $787K | Sell |
22,361
-5,811
| -21% | -$205K | 0.03% | 363 |
|
|
2022
Q4 | $1.29M | Buy |
28,172
+1,598
| +6% | +$73.2K | 0.05% | 317 |
|
|
2022
Q3 | $1.29M | Buy |
26,574
+931
| +4% | +$45.1K | 0.05% | 318 |
|
|
2022
Q2 | $1.01M | Buy |
+25,643
| New | +$1.01M | 0.04% | 355 |
|
|
2020
Q4 | – | Sell |
-30,491
| Closed | -$660K | – | 431 |
|
|
2020
Q3 | $660K | Buy |
+30,491
| New | +$660K | 0.02% | 379 |
|